Raymond James Financial Services Advisors Inc. Buys 1,745 Shares of VanEck Vectors Biotech ETF (NASDAQ:BBH)

Share on StockTwits

Raymond James Financial Services Advisors Inc. lifted its stake in shares of VanEck Vectors Biotech ETF (NASDAQ:BBH) by 41.1% in the second quarter, according to its most recent filing with the SEC. The fund owned 5,994 shares of the company’s stock after acquiring an additional 1,745 shares during the period. Raymond James Financial Services Advisors Inc. owned approximately 0.20% of VanEck Vectors Biotech ETF worth $977,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Institute for Wealth Management LLC. lifted its holdings in shares of VanEck Vectors Biotech ETF by 1.8% during the 1st quarter. Institute for Wealth Management LLC. now owns 5,966 shares of the company’s stock worth $764,000 after acquiring an additional 103 shares during the last quarter. Whittier Trust Co. bought a new stake in shares of VanEck Vectors Biotech ETF during the 1st quarter worth $26,000. First Manhattan Co. lifted its holdings in shares of VanEck Vectors Biotech ETF by 100.0% during the 1st quarter. First Manhattan Co. now owns 400 shares of the company’s stock worth $51,000 after acquiring an additional 200 shares during the last quarter. Advisors Preferred LLC purchased a new position in VanEck Vectors Biotech ETF in the 1st quarter worth $33,000. Finally, Boston Research & Management Inc. raised its position in VanEck Vectors Biotech ETF by 2.1% in the 1st quarter. Boston Research & Management Inc. now owns 14,443 shares of the company’s stock worth $1,848,000 after purchasing an additional 298 shares during the period. 19.70% of the stock is owned by institutional investors.

Separately, ValuEngine cut shares of VanEck Vectors Biotech ETF from a “hold” rating to a “sell” rating in a research report on Thursday, July 2nd.

Shares of NASDAQ:BBH opened at $164.85 on Friday. The company’s fifty day moving average is $165.43 and its 200 day moving average is $147.47. VanEck Vectors Biotech ETF has a 52 week low of $112.03 and a 52 week high of $178.10.

See Also: Equal Weight Rating

Want to see what other hedge funds are holding BBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Vectors Biotech ETF (NASDAQ:BBH).

Institutional Ownership by Quarter for VanEck Vectors Biotech ETF (NASDAQ:BBH)

Receive News & Ratings for VanEck Vectors Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Vectors Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

SG Americas Securities LLC Has $911,000 Holdings in United Bankshares, Inc.
SG Americas Securities LLC Has $911,000 Holdings in United Bankshares, Inc.
SG Americas Securities LLC Trims Stake in Alliant Energy Co.
SG Americas Securities LLC Trims Stake in Alliant Energy Co.
Raymond James Financial Services Advisors Inc. Takes $927,000 Position in Goldman Sachs ActiveBeta International Equity ETF
Raymond James Financial Services Advisors Inc. Takes $927,000 Position in Goldman Sachs ActiveBeta International Equity ETF
Raymond James Financial Services Advisors Inc. Has $929,000 Stock Position in Mylan NV
Raymond James Financial Services Advisors Inc. Has $929,000 Stock Position in Mylan NV
Raymond James Financial Services Advisors Inc. Sells 9,490 Shares of iShares Dow Jones U.S. ETF
Raymond James Financial Services Advisors Inc. Sells 9,490 Shares of iShares Dow Jones U.S. ETF
Crispr Therapeutics AG  Holdings Raised by Raymond James Financial Services Advisors Inc.
Crispr Therapeutics AG Holdings Raised by Raymond James Financial Services Advisors Inc.


© 2006-2020 Ticker Report